| K-number | K252128 |
| Device name | Zener® (model ZEN-001-B1) |
| Applicant | Uvx, Inc. |
| Product code | FRA |
| Device class | Class II |
| Decision date | Sep 15, 2025 |
| Decision | Substantially Equivalent |
| Regulation | 880.6500 |
Zener is a ceiling-mounted UV air purification device intended to reduce bacteria in air within medical facilities. It uses ultraviolet-C light to kill microorganisms and has demonstrated a 4.73 net log-reduction of Klebsiella aerogenes in a 1,060 cubic foot space within 2 hours at specified humidity and temperature conditions.
Zener uses one UV-C optic consuming 11W power with four cylindrical tubes operating at 200-235 nm wavelength, compared to the predicate's two 48W UV-C optics. Zener is ceiling-fixed at minimum 2.25 meters height and relies on ambient air circulation, whereas the predicate uses an internal fan to circulate air through a shielded chamber with a particulate filter. Both use quartz UV-C optics with no chemical additives or electrostatic precipitation.
Performance testing per ASHRAE 241 (modified for bacteria), AHAM AC-5, and FDA GLP; electrical safety per UL 1598 and CSA C22.2 No. 250.0; photobiological safety per IEC 62471 and ANSI/CAN/UL 8802; ozone safety per UL 867 and CSA C22.2 No. 187; electromagnetic compatibility per IEC 60601-1-2, CISPR 11, and FCC; software verification per IEC 62304; and risk management per ISO 14971.
Although Zener's design differs from the predicate (passive ambient air exposure versus active fan-driven circulation, different power consumption, and UV optic configuration), substantial equivalence is demonstrated through: (1) identical mechanism of action (UV light killing microorganisms), (2) same germicidal UV-C technology and wavelength range, (3) comparable performance metrics (4.73 log-reduction versus 4-5 log-reduction), (4) passing all applicable safety certifications and standards, and (5) risk analysis and performance testing confirming these design differences do not raise different safety or effectiveness questions.
View the full FDA submission: accessdata.fda.gov